Amicus Therapeutics, Inc.
FOLD
$14.38
$0.010.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -88.53% | 357.19% | -55.57% | 55.21% | 143.55% |
| Total Depreciation and Amortization | -7.06% | -13.64% | -15.12% | -14.72% | -6.46% |
| Total Amortization of Deferred Charges | 13.23% | 14.63% | 12.50% | 14.12% | 11.38% |
| Total Other Non-Cash Items | -16.71% | 2.86% | -0.37% | -45.27% | -33.76% |
| Change in Net Operating Assets | 84.67% | 77.52% | -361.92% | 126.93% | -6,384.34% |
| Cash from Operations | 515.04% | 255.24% | -216.90% | 126.13% | -213.24% |
| Capital Expenditure | -3.82% | -7.30% | -118.85% | 88.29% | 83.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 69.19% | -102.65% | 83.84% | -449.26% | 9.55% |
| Cash from Investing | 68.15% | -103.79% | 73.71% | -536.00% | 14.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -439.53% | -170.83% | 77.78% | 64.29% | 99.99% |
| Issuance of Common Stock | 851.27% | -98.38% | -95.37% | -96.96% | -93.90% |
| Repurchase of Common Stock | -438.65% | 41.22% | 74.35% | 29.49% | 47.09% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,178.85% | -107.25% | 53.33% | 12.09% | -86.64% |
| Foreign Exchange rate Adjustments | -110.59% | 76.13% | 3,496.94% | 365.36% | 179.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 216.69% | 30.16% | -5,098.40% | 14.21% | -24.14% |